// App-Quantinova.ai

: Allogeneic Transplant As a Curative Option for Relapsed/Refractory Large B-Cell Lymphoma in the Era of CAR T-Cell Therapy: A Monocentric Retrospective Study

Researchers

Presenter

  • Pauline Roché

Principal Investigators

  • Gabriel Brisou

  • Sabine Furst

  • Robin Noel

  • Catalina Montes De Oca

  • Aude Collignon

  • Luca Inchiappa

  • Jean Marc Schiano De Colella

  • Isabelle Brenot Rossi

  • Thibaut Reichert

  • Sophie Thévenet

  • Bechara Mfarrej

  • Boris Calmels

  • Didier Blaise

  • Christian Chabannon

  • Raynier Devillier

Medical Centers

  • Cell Therapy Facility, Institut Paoli-Calmettes, Marseille, France

  • Hematology Department, Institut Paoli-Calmettes, Marseille, France

  • Nuclear Medicine Department, Institut Paoli-Calmettes, Marseille, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Mucosa-associated lymphoid tissue lymphoma

  • B cell lymphomas

Biomarkers

  • B-cell lymphoma 2

  • B-cell lymphoma 6

  • cMYC

  • Estrogen receptor alpha

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved